Special Session

Presidential Symposium II - EL03 - Imaging at the Micrometer Scale is Possible and Required for RT to Cure Metastatic Disease

9/15/2019
10:15 AM - 11:45 AM
Location: Room W178

Session Type: Special Session
0.00 AMA PRA Category 1 Credits™

We will review the currently available imaging modalities for high sensitivity detection of metastatic disease, and discuss the practicalities of integrating these imaging modalities into patient management. We will debate and discuss the following topics: 1) Is radiation is needed to clear micrometer scale disease, or could systemic therapy achieve this goal? 2) How should we use imaging advancements to improve radiation therapy; and 3) What are ideal imaging targets and how do we select from what is currently available?

During this session attendees will be engaged in mini debates. The session will begin with 2 level setting talks and then attendees will be presented 3 different topics sequentially with time to have small group discussion and mini debates after each topic presentation. The session will end with a wrap-up and take home message.

Presentations:

Jing Zeng, MD

University of Washington

Disclosure:
Employment
University of Washington: Associate Professor: Employee

Presentation(s):

Send Email for Jing Zeng

Aparna Kesarwala, MD, PhD

Emory University

Disclosure:
Employment
National Cancer Institute: Asst Research Physician: Employee

Presentation(s):

Send Email for Aparna Kesarwala

Eric Mellon, MD, PhD

University of Miami

Disclosure:
Employment
University of Miami: Assistant Professor of Radiation Oncology: Employee

Compensation
ViewRay: Travel Expenses

Biography:
Eric A. Mellon, MD, PhD is an Assistant Professor of the Departments of Radiation Oncology and Bioengineering at the University of Miami, Sylvester Comprehensive Cancer Center, Miller School of Medicine. He is a board certified radiation oncologist and graduate of the Physician Scientist Training Program of the University of Pennsylvania where he earned his PhD in MRI Physics.

Dr. Mellon has published over forty peer-reviewed articles on emerging MRI techniques for cancer and clinical radiation oncology--mostly in brain and pancreatic cancers. Clinically, he specializes in radiotherapy for tumors of the central nervous sytem and serves as co-leader of the neurologic cancer site disease group at the Sylvester Cancer Center. He is principal investigator and co-investigator on two NIH-funded trials for magnetic resonance spectroscopy guided radiotherapy of glioblastoma and assessment of response to therapy for brain metastases. His current basic research interests utilize MRI to probe the tumor microenvironment during therapy, giving information beyond just tumor size to evaluate early treatment response.

Presentation(s):

Send Email for Eric Mellon


Assets

Presidential Symposium II - EL03 - Imaging at the Micrometer Scale is Possible and Required for RT to Cure Metastatic Disease



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Presidential Symposium II - EL03 - Imaging at the Micrometer Scale is Possible and Required for RT to Cure Metastatic Disease